Seemed like a slow news day as the markets pulled back to consolidate some of the recent moves. Biotechs were not immune to the move, although some clearly performed better.
Well, there was not a lot of news out there in biotech land but oddly there is a lot I want to talk about and will work through it over.
Got some interesting news today, which makes this a little more exciting but still not a huge news day (the theme for the week). There will not by a note.
Perhaps we were spoiled last week with the ONXX news but this week seems to be getting off to a slow start. There were some decent sized moves in biotech.
I wanted to follow up on the discussion of yesterday less with an analysis of the potential dance partners for ONXX but more in terms of where do we go.
Not much of a lot of new today but there were some interesting tidbits. 1. BIIB spiked higher today on the back of SNY news. The EMA granted Aubagio exclusivity.
Generally it was a good bounce back day for a lot of biotechs, although there were some pockets of underperformance. That being said, this is a positive day but the.
There was a lot that happened last week that I will slowly get to go through it the next week but on a big picture macro front, I actually think.
Was a quiet day on the news front, so I will keep this short(er). I am just getting a sneaking suspicion that we are heading into another period where macro.
It was an odd day in the market with weakness early followed but a rally in the afternoon that made it look like we would get to unchanged (or even.